Reading the glycome in MASLD: at the crossroads of metabolism and inflammation.

IF 4.8 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Javier Crespo, Paula Iruzubieta
{"title":"Reading the glycome in MASLD: at the crossroads of metabolism and inflammation.","authors":"Javier Crespo, Paula Iruzubieta","doi":"10.17235/reed.2026.12254/2026","DOIUrl":null,"url":null,"abstract":"<p><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as the hepatic expression of a broader cardiometabolic and inflammatory disorder. In this context, circulating glycoprotein signals may provide information beyond conventional assessment of steatosis and fibrosis risk. García-Mateo et al. evaluated plasma Glyc-A, Glyc-B and Glyc-F using nuclear magnetic resonance in patients with inflammatory bowel disease (IBD), with and without MASLD, and in matched controls. Glycoprotein concentrations showed a progressive increase from controls to IBD and were highest when IBD and MASLD coexisted, while Glyc-B and Glyc-F remained independently associated with MASLD after adjustment for relevant metabolic variables. These findings should not yet be interpreted as establishing new clinical biomarkers. Rather, they raise a more fundamental question: what biological information is captured by circulating glycoprotein signals? Glyc-A, Glyc-B and Glyc-F represent composite spectroscopic signals influenced by acute-phase proteins, systemic inflammation, metabolic dysfunction and, potentially, disease-specific glycan changes. Their interpretation is therefore particularly relevant in IBD, where immune-mediated inflammation may modify the metabolic and hepatic phenotype. Emerging transcriptomic and glycomic data suggest that MASLD arising in different inflammatory contexts may not be biologically identical, despite a similar clinical classification. The current evidence supports the biological plausibility of glycoprotein profiling but not yet its routine clinical use. Future studies should determine the relative contribution of systemic inflammation, adiposity, insulin resistance, dyslipidaemia and liver injury to these signals; establish their relationship with clinically relevant liver phenotypes, particularly fibrosis; and demonstrate incremental value beyond established non-invasive tools. Learning to interpret the glycome may ultimately prove more informative than simply measuring it.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":"118 ","pages":"552-555"},"PeriodicalIF":4.8000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Enfermedades Digestivas","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17235/reed.2026.12254/2026","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as the hepatic expression of a broader cardiometabolic and inflammatory disorder. In this context, circulating glycoprotein signals may provide information beyond conventional assessment of steatosis and fibrosis risk. García-Mateo et al. evaluated plasma Glyc-A, Glyc-B and Glyc-F using nuclear magnetic resonance in patients with inflammatory bowel disease (IBD), with and without MASLD, and in matched controls. Glycoprotein concentrations showed a progressive increase from controls to IBD and were highest when IBD and MASLD coexisted, while Glyc-B and Glyc-F remained independently associated with MASLD after adjustment for relevant metabolic variables. These findings should not yet be interpreted as establishing new clinical biomarkers. Rather, they raise a more fundamental question: what biological information is captured by circulating glycoprotein signals? Glyc-A, Glyc-B and Glyc-F represent composite spectroscopic signals influenced by acute-phase proteins, systemic inflammation, metabolic dysfunction and, potentially, disease-specific glycan changes. Their interpretation is therefore particularly relevant in IBD, where immune-mediated inflammation may modify the metabolic and hepatic phenotype. Emerging transcriptomic and glycomic data suggest that MASLD arising in different inflammatory contexts may not be biologically identical, despite a similar clinical classification. The current evidence supports the biological plausibility of glycoprotein profiling but not yet its routine clinical use. Future studies should determine the relative contribution of systemic inflammation, adiposity, insulin resistance, dyslipidaemia and liver injury to these signals; establish their relationship with clinically relevant liver phenotypes, particularly fibrosis; and demonstrate incremental value beyond established non-invasive tools. Learning to interpret the glycome may ultimately prove more informative than simply measuring it.

在代谢和炎症的十字路口阅读MASLD中的血糖。
代谢功能障碍相关脂肪变性肝病(MASLD)越来越被认为是一种更广泛的心脏代谢和炎症性疾病的肝脏表达。在这种情况下,循环糖蛋白信号可能提供超出常规脂肪变性和纤维化风险评估的信息。García-Mateo等人使用核磁共振技术对炎症性肠病(IBD)患者(伴或不伴MASLD)以及匹配对照的血浆Glyc-A、Glyc-B和Glyc-F进行评估。从对照组到IBD,糖蛋白浓度逐渐增加,当IBD和MASLD共存时,糖蛋白浓度最高,而在调整相关代谢变量后,Glyc-B和Glyc-F仍与MASLD独立相关。这些发现还不应该被解释为建立新的临床生物标志物。相反,它们提出了一个更基本的问题:循环的糖蛋白信号捕获了哪些生物信息?Glyc-A、Glyc-B和Glyc-F代表受急性期蛋白、全身炎症、代谢功能障碍以及潜在的疾病特异性聚糖变化影响的复合光谱信号。因此,他们的解释与IBD特别相关,其中免疫介导的炎症可能改变代谢和肝脏表型。新出现的转录组学和糖组学数据表明,尽管临床分类相似,但不同炎症背景下发生的MASLD在生物学上可能并不相同。目前的证据支持糖蛋白谱分析的生物学合理性,但尚未常规临床应用。未来的研究应确定全身性炎症、肥胖、胰岛素抵抗、血脂异常和肝损伤对这些信号的相对贡献;建立它们与临床相关的肝脏表型,特别是纤维化的关系;并展示超出现有非侵入性工具的增量价值。学习解释血糖可能最终证明比简单地测量它更有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
25.00%
发文量
400
审稿时长
6-12 weeks
期刊介绍: La Revista Española de Enfermedades Digestivas, Órgano Oficial de la Sociedad Española de Patología Digestiva (SEPD), Sociedad Española de Endoscopia Digestiva (SEED) y Asociación Española de Ecografía Digestiva (AEED), publica artículos originales, editoriales, revisiones, casos clínicos, cartas al director, imágenes en patología digestiva, y otros artículos especiales sobre todos los aspectos relativos a las enfermedades digestivas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书